Free Trial
→ First Look: Elon’s “Starphone” (From Stansberry Research) (Ad)tc pixel Free LYEL Stock Alerts

Lyell Immunopharma (LYEL) Institutional Ownership

Lyell Immunopharma logo
$8.71 -0.08 (-0.91%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$8.70 -0.01 (-0.06%)
As of 10/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Lyell Immunopharma (NASDAQ:LYEL)

Current
Institutional Ownership
Percentage
66.05%
Number of
Institutional Buyers
(last 12 months)
28
Total
Institutional Inflows
(last 12 months)
$124.98M
Number of
Institutional Sellers
(last 12 months)
9
Total
Institutional Outflows
(last 12 months)
$8.86M
Get LYEL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lyell Immunopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

LYEL Institutional Buying and Selling by Quarter

Lyell Immunopharma Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/9/2026Opaleye Management Inc.344,025$4.83M0.4%+334.9%1.404%
9/9/2026Squarepoint Ops LLC42,322$595K0.0%+119.4%0.173%
8/21/2026Velan Capital Investment Management LP105,000$1.48M0.9%+2.9%0.429%
8/18/2026venBio Partners LLC337,697$4.74M0.0%N/A1.378%
8/6/2026Bank of New York Mellon Corp24,673$347K0.0%N/A0.101%
5/19/2026Bank of America Corp DE33,321$668K0.0%+314.2%0.143%
5/19/2026RBF Capital LLC44,094$885K0.0%-40.9%0.189%
5/14/2026Renaissance Technologies LLC116,411$2.34M0.0%+194.8%0.499%
5/14/2026Walleye Capital LLC22,207$445K0.0%N/A0.095%
5/7/2026Dimensional Fund Advisors LP47,888$959K0.0%N/A0.205%
2/19/2026Invesco Ltd.98,649$3.04M0.0%N/A0.464%
2/18/2026venBio Partners LLC337,697$10.39M4.8%-28.7%1.590%
2/18/2026Ikarian Capital LLC41,081$1.26M0.1%-6.2%0.193%
2/18/2026Millennium Management LLC58,651$1.81M0.0%-53.2%0.276%
2/18/2026MWG Caph Ltd1,008,116$31.03M42.9%N/A4.746%
2/18/2026Boothbay Fund Management LLC9,516$293K0.0%-22.2%0.045%
2/17/2026ExodusPoint Capital Management LP8,511$262K0.0%N/A0.040%
2/17/2026RBF Capital LLC74,585$2.30M0.1%-22.0%0.351%
2/16/2026Barclays PLC15,967$491K0.0%+1,239.5%0.075%
2/13/2026Marshall Wace LLP73,315$2.26M0.0%N/A0.345%
2/13/2026Charles Schwab Investment Management Inc.85,423$2.63M0.0%+7.4%0.402%
2/13/2026State Street Corp51,472$1.58M0.0%+52.5%0.242%
2/12/2026Jane Street Group LLC12,409$382K0.0%N/A0.058%
2/12/2026GSK plc1,512,659$46.56M5.8%N/A7.122%
2/12/2026Renaissance Technologies LLC39,490$1.22M0.0%-38.3%0.186%
2/11/2026BBR Partners LLC6,834$210K0.0%N/A0.032%
2/10/2026Goldman Sachs Group Inc.96,675$2.98M0.0%N/A0.455%
2/9/2026Geode Capital Management LLC162,997$5.02M0.0%+25.1%0.767%
11/17/2025Susquehanna International Group LLP16,159$262K0.0%-27.9%0.076%
11/17/2025Millennium Management LLC125,361$2.04M0.0%+140.0%0.591%
11/17/2025Foresite Capital Management V LLC477,078$7.75M7.1%+17.3%2.248%
11/17/2025Bank of America Corp DE4,679$76K0.0%-80.3%0.022%
11/17/2025Almitas Capital LLC577,807$9.38M2.1%-0.4%2.723%
11/14/2025ARCH Venture Management LLC2,759,072$44.81M9.1%+51.5%14.362%
11/14/2025Two Sigma Investments LP20,827$338K0.0%+107.0%0.108%
11/13/2025Takeda Pharmaceutical Co. Ltd.54,887$891K5.4%+33.3%0.286%
11/7/2025Vanguard Group Inc.779,004$12.65M0.0%+76.0%4.055%
10/14/2025Clarius Group LLC19,958$324K0.0%+4.3%0.104%
8/28/2025China Universal Asset Management Co. Ltd.2,966$26K0.0%-94.9%0.015%
8/15/2025Orland Properties Ltd754,698$6.67M2.8%-95.0%3.929%
Why I went to Mount Rushmore (Ad)

A small miner just hit on gold in the hills surrounding Mount Rushmore, thanks to a breakthrough new technology. This could be one of the biggest gold finds since the 1870s, yet the stock still trades around 6 dollars. BlackRock and Vanguard have been quietly loading up on shares while most investors have missed the story. The same technology is unlocking hidden resource wealth across America, driving stocks up 227 percent, 378 percent, and even 773 percent.tc pixel

Watch the free video and get the stock name now
8/15/2025MWG Management Ltd.1,008,116$8.91M17.2%-95.0%5.248%
8/15/2025HSG Holding Ltd152,299$1.35M0.1%-95.0%0.793%
8/15/2025Boothbay Fund Management LLC12,234$108K0.0%-95.0%0.064%
8/15/2025Bridgeway Capital Management LLC18,000$159K0.0%N/A0.094%
8/15/2025Bank of America Corp DE23,758$210K0.0%-74.7%0.124%
8/15/2025ARCH Venture Management LLC1,820,634$16.11M5.4%N/A9.478%
8/14/2025Orbimed Advisors LLC51,727$457K0.0%N/A0.335%
8/14/2025Raymond James Financial Inc.7,900$70K0.0%-95.0%0.051%
8/14/2025Canada Pension Plan Investment Board29,411$260K0.0%-95.0%0.190%
8/14/2025The Manufacturers Life Insurance Company 24,419$216K0.0%-95.2%0.158%
8/14/2025RBF Capital LLC100,000$884K0.0%N/A0.647%
8/13/2025Marshall Wace LLP10,580$94K0.0%N/A0.068%
8/13/2025Walleye Capital LLC29,230$258K0.0%N/A0.189%
8/13/2025Decheng Capital LLC595,466$5.26M1.2%-95.0%3.852%
8/13/2025Invesco Ltd.12,809$113K0.0%-96.6%0.083%
8/12/2025Foresite Capital Management V LLC406,652$3.60M4.5%-95.0%2.630%
8/12/2025Foresite Capital Management IV LLC800,399$7.08M5.7%-95.0%5.177%
8/12/2025JPMorgan Chase & Co.3,369$30K0.0%-98.3%0.022%
8/8/2025Geode Capital Management LLC103,270$913K0.0%-97.7%0.668%
8/8/2025Takeda Pharmaceutical Co. Ltd.41,165$364K1.9%-95.0%0.266%
8/1/2025Alphabet Inc.293,256$2.59M0.1%-95.0%1.980%
7/28/2025TD Asset Management Inc50,232$444K0.0%-95.0%0.339%
7/22/2025Johnson & Johnson41,165$368K0.1%-95.0%0.278%
7/22/2025Clarius Group LLC19,138$169K0.0%-95.2%0.129%
6/27/2025Goldman Sachs Group Inc.358,592$193K0.0%-42.8%2.421%
6/18/2025Voya Investment Management LLC50,329$27K0.0%-4.9%0.340%
5/29/2025Rhumbline Advisers235,694$127K0.0%-16.2%0.080%
5/21/2025Acadian Asset Management LLC660,899$354K0.0%+204.2%0.224%
5/19/2025Jane Street Group LLC64,241$35K0.0%-73.2%0.022%
5/16/2025Goldman Sachs Group Inc.358,592$193K0.0%-42.8%0.121%
5/16/2025Jacobs Levy Equity Management Inc.558,979$301K0.0%-59.6%0.189%
5/16/2025AQR Capital Management LLC174,279$94K0.0%+773.5%0.059%
5/16/2025Almitas Capital LLC2,482,606$1.34M0.4%+136.3%0.841%
5/12/2025Nuveen LLC641,173$345K0.0%N/A0.217%
5/12/2025Invesco Ltd.378,880$204K0.0%-7.0%0.128%
5/9/2025Charles Schwab Investment Management Inc.1,604,676$863K0.0%-2.5%0.543%
4/17/2025Exchange Traded Concepts LLC246,349$133K0.0%+82.4%0.083%
4/8/2025Rhumbline Advisers235,694$127K0.0%-16.2%0.080%
2/19/2025Public Employees Retirement System of Ohio99,307$64K0.0%N/A0.034%
2/17/2025venBio Partners LLC7,102,190$4.55M2.7%N/A2.431%
2/17/2025Two Sigma Investments LP204,501$131K0.0%-15.4%0.070%
2/17/2025Two Sigma Advisers LP306,400$196K0.0%+143.8%0.105%
2/17/2025Nuveen Asset Management LLC641,173$410K0.0%-25.1%0.219%
2/17/2025Orbimed Advisors LLC3,103,623$1.99M0.0%-49.0%1.062%
2/17/2025Millennium Management LLC957,507$613K0.0%+34.8%0.328%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.308,551$197K0.0%+13.4%0.106%
2/17/2025Jacobs Levy Equity Management Inc.1,385,301$887K0.0%N/A0.474%
2/17/2025Graham Capital Management L.P.52,136$33K0.0%N/A0.018%
2/17/2025Foresite Capital Management V LLC8,133,047$5.21M4.3%N/A2.784%
2/17/2025D. E. Shaw & Co. Inc.966,265$618K0.0%+104.4%0.331%
First Look: Elon’s “Starphone” (Ad)

Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that.tc pixel

See the full evidence behind Elon Musk's rumored new device.
2/17/2025BNP Paribas Financial Markets253,669$162K0.0%N/A0.087%
2/17/2025Almitas Capital LLC1,050,520$672K0.1%N/A0.360%
2/14/2025Jane Street Group LLC239,439$153K0.0%-16.8%0.082%
2/14/2025Northern Trust Corp1,310,224$839K0.0%-3.4%0.448%
2/14/2025Decheng Capital LLC11,909,341$7.62M1.6%N/A4.076%
2/14/2025Boothbay Fund Management LLC406,234$260K0.0%+190.4%0.139%
2/14/2025Price T Rowe Associates Inc. MD6,910,749$4.42M0.0%-6.0%2.365%
2/14/2025Johnson & Johnson823,317$527K0.1%N/A0.282%
2/13/2025Barclays PLC258,380$165K0.0%+7.4%0.088%
2/13/2025Renaissance Technologies LLC1,612,146$1.03M0.0%+716.7%0.552%


LYEL Institutional Ownership - Frequently Asked Questions

During the previous two years, 78 institutional investors and hedge funds held shares of Lyell Immunopharma. The most heavily invested institutionals were GSK plc ($46.56M), ARCH Venture Management LLC ($44.81M), MWG Caph Ltd ($31.03M), Vanguard Group Inc. ($12.65M), WuXi AppTec Co. Ltd. ($10.20M), Almitas Capital LLC ($9.38M), and MWG Management Ltd. ($8.91M).Learn more on Lyell Immunopharma's institutional investors.

66.05% of Lyell Immunopharma's stock is owned by institutional investors. Learn more on LYEL's institutional investor holdings.

Of the 56 institutional investors that purchased Lyell Immunopharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Decheng Capital LLC ($11.91M), Foresite Capital Management V LLC ($8.20M), venBio Partners LLC ($7.44M), ARCH Venture Management LLC ($2.76M), Almitas Capital LLC ($2.48M), GSK plc ($1.51M), and Renaissance Technologies LLC ($1.49M).

Institutional investors have bought a total of 5,157,618 shares in the last 24 months. This purchase volume represents approximately $124.98M in transactions.

Of the 9 institutional investors that sold Lyell Immunopharma's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: venBio Partners LLC ($135.78K), Millennium Management LLC ($66.71K), RBF Capital LLC ($51.54K), Renaissance Technologies LLC ($24.50K), Bank of America Corp DE ($19.08K), Susquehanna International Group LLP ($6.24K), and Boothbay Fund Management LLC ($2.72K).

Institutional investors have sold a total of 311,475 shares in the last 24 months. This volume of shares sold represents approximately $8.86M in transactions.


Related Companies

Institutional ownership data for NASDAQ:LYEL is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/9/2026. New 13F filings are added each quarter as they're published.
From Our Partners
A Simple Guide to Options Trading While It's Still Free
A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...
True Market Insiders | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
This free guide explains options the way they should be taught
Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...
Base Camp Trading | Sponsoredtc pixel
Trump’s issues shocking Executive Order on U.S. Dollar
Three days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....
Banyan Hill Publishing | Sponsoredtc pixel
A simple options setup that cuts through the noise
Ian Cooper says most options traders overcomplicate the process, juggling countless indicators, strategies, an...
TradeWins | Sponsoredtc pixel
The trade I’ve been waiting for since 2011
Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...
Traders Agency | Sponsoredtc pixel
Look at Elon’s face after meeting with China
Elon Musk recently met with Chinese President Xi Jinping, and a former Wall Street Journal Personal Finance Ex...
International Living | Sponsoredtc pixel
The only 5 stocks that matter
SpaceX's IPO reportedly minted 4,400 new millionaires, and OpenAI is said to be eyeing a 1 trillion dollar IPO...
TradeSmith | Sponsoredtc pixel